Downtown Richmond will become a sea of lights and a beacon of hope on the evening of Saturday, October 15th , as more than 1500 walkers join together to walk with illuminated lanterns at the Richmond Light The Night Walk® to benefit the Leukemia and Lymphoma Society (LLS).
Light the Night is an evening of hope, inspiration and celebration for blood cancer patients and their supporters throughout central Virginia and beyond. The Light The Night Walk is an annual fundraising campaign benefiting LLS and their funding of research to find blood cancer cures.
Light The Night is a powerful and unique fundraising campaign bringing families and businesses together to honor blood cancer survivors and those lost to the disease. The event shines a light on the importance of finding cures and providing access to treatments for blood cancer patients.
Walkers who raise $100 or more receive a Light The Night t-shirt, dinner, and an illuminated lantern that is symbolic of why they are walking—red for supporters, white for survivors, or gold in memory of those lost to cancer. Together, we form a community in support of cures for blood cancers and hope for victims and their families.
We invite all to participate, registration opens at 5:00 p.m. at Gamble Hill Park. The event includes children’s activities including a moon bounce and face painting, as well as entertainment and a Remembrance Ceremony at 6:00 p.m. The short walk starts at 7:00 p.m.
Thank you to Dan Weekley from Dominion for serving as the 2016 Richmond Light The Night® Corporate Walk Chair and to Dominion, our Presenting Sponsor. Thanks also to other top sponsors Massey Cancer Center, Children’s Hospital of Richmond at VCU, Union Bank & Trust, Bon Secours, Columbia Gas of Virginia, Deloitte, HCA/Sarah Cannon, McGuireWoods, New Market, PricewaterhouseCoopers and the Virginia Cancer Institute for their support.
LLS has invested over a billion dollars into blood cancer research. LLS was involved in the development of virtually every treatment available today for blood cancer patients. Since 2001, 40% of the treatments first approved to treat blood cancers are now being used to treat lung, prostate, ovarian, breast, pancreatic and colon cancers.
Research is the crown jewel of LLS. We are currently funding over 300 research projects worldwide. LLS support is driving amazing advances. Since July of 2015, 6 new agents have been approved by the FDA: 3 for Myeloma, 2 for Lymphoma, and 1 for Hodgkin’s Lymphoma; and the FDA has designated “breakthrough status” to 8 new agents pending approval including the first new treatment for AML in over 40 years.
LLS also directly helps patients, through our Co-Pay & Travel Assistance programs which provided $942,000 to 493 patients in just Virginia. LLS is one of the few organizations providing financial aid to patients. Around $45 million nationally.
To learn more about The Leukemia and Lymphoma Society please visit http://www.lls.org/ or reach out to Virginia Chapter staff at (804) 673-5690.